Actually quiet the opposite the trial needed to have a unfortunately significant amount of deaths in order to hit pvalue. No drug has shown even modest reduction in mortality all trials failed most changed endpoints before trials even finished. No one is expecting 50+ % reduction in mortality however 20%--30% would be great reduction for immediate EUA if mortality is 30%+ full approval would be likely.